PGNY Progyny

Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl

Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded in 2019. This acquisition enhances Progyny’s guided, concierge support that enables employees around the world to navigate the complexities of fertility and family building care.

Progyny’s global benefits solution supports multinational employers and their employee populations in over 100 countries. Progyny’s services allow employers the flexibility to offer fertility and family building benefits that comply with the intricacies of country-specific laws and regulations as it relates to fertility and family building services, treatments, and benefit design.

“Employers recognize the importance of providing fertility and family building benefits and want to be able to streamline these efforts to ensure their employees have equitable benefits and consistent high-touch experiences, regardless of where they live,” said Pete Anevski, CEO of Progyny. “We’re excited to broaden our support on a global scale.”

Progyny’s enhanced global services include:

  • Holistic support across preconception, fertility, fertility treatments, adoption, and surrogacy
  • A streamlined patient experience with personalized concierge support
  • Access to thousands of vetted fertility clinics
  • Secure financial processing in the member’s local currency
  • A seamless benefit integration and implementation with ability to customize by country
  • Secure and GDPR compliant platform, which safeguards employee data and provides stringent fraud detection, ensuring services and claims meet local regulations and laws

Jenny Saft, co-founder of Apryl, said, “We saw the incredible solution and impact Progyny had created in the U.S. and founded Apryl with the vision of achieving this success globally. The Apryl team is thrilled to join Progyny to bring employers and their employees around the world access to best-in-class benefits that make dreams of family come true.”

For more information about Progyny visit .

About Progyny

Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians. 

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.  

Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit . 

For Further Information, Please Contact:

Investors:

James Hart

Media:

Selena Yang



EN
24/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

 PRESS RELEASE

Progyny, Inc. to Host 2024 Inaugural Investor Day

Progyny, Inc. to Host 2024 Inaugural Investor Day NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time until approximately 1:00 P.M. Eastern Time. Progyny’s executives, along with other members of the senior leadership team, will present an overview of the Company’s business and its growth opportunities. During the meeting, there will be time allotted ...

 PRESS RELEASE

Progyny, Inc. Announces Enhanced Global Services with Acquisition of A...

Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded in 2019. This acquisition enhances Progyny’s guided, concierge support that enables employees around the world to navigate the complexities of fertility and family building care. Progyny’s global benefits solution supports multi...

 PRESS RELEASE

New Survey from Progyny Shows Strong LGBTQ+ Demand for Inclusive Famil...

New Survey from Progyny Shows Strong LGBTQ+ Demand for Inclusive Family Building Benefits NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today released findings from its 2024 LGBTQ+ family building survey. The report, which surveyed over 1,100 LGBTQ+ individuals in the U.S. planning to build their families, highlights the unique challenges LGBTQ+ patients face, including struggles with insufficient access to care, financial constraints, and lack of mental health support throughout...

 PRESS RELEASE

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

Progyny, Inc. to Present at Jefferies Global Healthcare Conference NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 9:00 A.M. Eastern Time. A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at About Progyny Progyny (Nasdaq: PGNY) is a transf...

 PRESS RELEASE

Progyny, Inc. Announces Additional Share Repurchase Program

Progyny, Inc. Announces Additional Share Repurchase Program NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common stock. This follows the program that was previously announced on February 29, 2024. The program will be funded through available cash balances. Shares may be repurchased through open market repurchases, including through plans complying with Rule ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch